Search

Search Constraints

You searched for: Author/Creator Gillessen, S

Search Results

1. 1703PIncidence of hypocalcemia in a non-inferiority phase III trial assessing prevention of symptomatic skeletal events (SSE) with denosumab (DN) administered every 4 weeks (q4w) versus every 12 weeks (q12w): SAKK 96/12 (REDUSE). (23rd October 2018)

4. 814PPlatinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: A multicentre retrospective analysis. (23rd October 2018)

6. A parameter survey of Sgr A* radiative models from GRMHD simulations with self-consistent electron heating. Issue 3 (7th April 2020)

7. Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol. (26th February 2018)

8. Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial. (27th September 2019)

9. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. (19th November 2019)

10. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. (3rd August 2018)